APO Research
Talk to an analyst

APO RESEARCH · REPORT

Buspirone

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Buspirone Market Analysis and Forecast 2026-2032

19 December 2025191 pages

Choose your research edition.

Industry ResearchBuspirone Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Buspirone Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Buspirone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Buspirone Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Buspirone Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Buspirone market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Buspirone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Buspirone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Buspirone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Buspirone is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Buspirone include Teva, Novartis, Mylan, Wockhardt, Watson Laboratories, Orion Corporation, Laboratoires Servier, Hikma and Dr. Reddy's Laboratories, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Buspirone, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Buspirone, also provides the sales of main regions and countries. Of the upcoming market potential for Buspirone, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Buspirone sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Buspirone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Buspirone sales, projected growth trends, production technology, application and end-user industry.

Buspirone Segment by Company

Teva

Novartis

Mylan

Wockhardt

Watson Laboratories

Orion Corporation

Laboratoires Servier

Hikma

Dr. Reddy's Laboratories

Cadila Healthcare

Bristol Myers Squibb

Apotex

AMAG Pharmaceuticals

Buspirone Segment by Type

10mg

15mg

30mg

5mg

Buspirone Segment by Application

Hospital

Drug Store

Buspirone Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Buspirone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Buspirone and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Buspirone.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Buspirone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Buspirone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Buspirone sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Buspirone Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 10mg Major Manufacturers Table 3. 15mg Major Manufacturers Table 4. 30mg Major Manufacturers Table 5. 5mg Major Manufacturers Table 6. Global Buspirone Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Manufacturers Table 8. Drug Store Major Manufacturers Table 9. Buspirone Industry Trends Table 10. Buspirone Industry Drivers Table 11. Buspirone Industry Opportunities and Challenges Table 12. Buspirone Industry Restraints Table 13. Global Buspirone Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Buspirone Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Buspirone Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Buspirone Revenue Market Share by Region (2021-2026) Table 17. Global Buspirone Revenue Market Share by Region (2027-2032) Table 18. Global Buspirone Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Buspirone Sales by Region (2021-2026) & (K Units) Table 20. Global Buspirone Sales by Region (2027-2032) & (K Units) Table 21. Global Buspirone Sales Market Share by Region (2021-2026) Table 22. Global Buspirone Sales Market Share by Region (2027-2032) Table 23. Global Buspirone Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Buspirone Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Buspirone Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Buspirone Sales Market Share by Manufacturers (2021-2026) Table 27. Global Buspirone Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Buspirone Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Buspirone Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Buspirone Manufacturers, Product Type & Application Table 31. Global Buspirone Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Buspirone by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Buspirone Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Buspirone Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Buspirone Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Buspirone Revenue Market Share by Type (2021-2026) Table 38. Global Buspirone Revenue Market Share by Type (2027-2032) Table 39. Global Buspirone Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Buspirone Sales by Type (2021-2026) & (K Units) Table 41. Global Buspirone Sales by Type (2027-2032) & (K Units) Table 42. Global Buspirone Sales Market Share by Type (2021-2026) Table 43. Global Buspirone Sales Market Share by Type (2027-2032) Table 44. Global Buspirone Price by Type (2021-2026) & (US$/Unit) Table 45. Global Buspirone Price by Type (2027-2032) & (US$/Unit) Table 46. Global Buspirone Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Buspirone Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Buspirone Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Buspirone Revenue Market Share by Application (2021-2026) Table 50. Global Buspirone Revenue Market Share by Application (2027-2032) Table 51. Global Buspirone Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Buspirone Sales by Application (2021-2026) & (K Units) Table 53. Global Buspirone Sales by Application (2027-2032) & (K Units) Table 54. Global Buspirone Sales Market Share by Application (2021-2026) Table 55. Global Buspirone Sales Market Share by Application (2027-2032) Table 56. Global Buspirone Price by Application (2021-2026) & (US$/Unit) Table 57. Global Buspirone Price by Application (2027-2032) & (US$/Unit) Table 58. Teva Company Information Table 59. Teva Business Overview Table 60. Teva Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Teva Buspirone Product Portfolio Table 62. Teva Recent Development Table 63. Novartis Company Information Table 64. Novartis Business Overview Table 65. Novartis Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Novartis Buspirone Product Portfolio Table 67. Novartis Recent Development Table 68. Mylan Company Information Table 69. Mylan Business Overview Table 70. Mylan Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Mylan Buspirone Product Portfolio Table 72. Mylan Recent Development Table 73. Wockhardt Company Information Table 74. Wockhardt Business Overview Table 75. Wockhardt Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Wockhardt Buspirone Product Portfolio Table 77. Wockhardt Recent Development Table 78. Watson Laboratories Company Information Table 79. Watson Laboratories Business Overview Table 80. Watson Laboratories Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Watson Laboratories Buspirone Product Portfolio Table 82. Watson Laboratories Recent Development Table 83. Orion Corporation Company Information Table 84. Orion Corporation Business Overview Table 85. Orion Corporation Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Orion Corporation Buspirone Product Portfolio Table 87. Orion Corporation Recent Development Table 88. Laboratoires Servier Company Information Table 89. Laboratoires Servier Business Overview Table 90. Laboratoires Servier Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Laboratoires Servier Buspirone Product Portfolio Table 92. Laboratoires Servier Recent Development Table 93. Hikma Company Information Table 94. Hikma Business Overview Table 95. Hikma Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Hikma Buspirone Product Portfolio Table 97. Hikma Recent Development Table 98. Dr. Reddy's Laboratories Company Information Table 99. Dr. Reddy's Laboratories Business Overview Table 100. Dr. Reddy's Laboratories Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Dr. Reddy's Laboratories Buspirone Product Portfolio Table 102. Dr. Reddy's Laboratories Recent Development Table 103. Cadila Healthcare Company Information Table 104. Cadila Healthcare Business Overview Table 105. Cadila Healthcare Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Cadila Healthcare Buspirone Product Portfolio Table 107. Cadila Healthcare Recent Development Table 108. Bristol Myers Squibb Company Information Table 109. Bristol Myers Squibb Business Overview Table 110. Bristol Myers Squibb Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Bristol Myers Squibb Buspirone Product Portfolio Table 112. Bristol Myers Squibb Recent Development Table 113. Apotex Company Information Table 114. Apotex Business Overview Table 115. Apotex Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Apotex Buspirone Product Portfolio Table 117. Apotex Recent Development Table 118. AMAG Pharmaceuticals Company Information Table 119. AMAG Pharmaceuticals Business Overview Table 120. AMAG Pharmaceuticals Buspirone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. AMAG Pharmaceuticals Buspirone Product Portfolio Table 122. AMAG Pharmaceuticals Recent Development Table 123. North America Buspirone Revenue by Type (2021-2026) & (US$ Million) Table 124. North America Buspirone Revenue by Type (2027-2032) & (US$ Million) Table 125. North America Buspirone Sales by Type (2021-2026) & (K Units) Table 126. North America Buspirone Sales by Type (2027-2032) & (K Units) Table 127. North America Buspirone Sales Price by Type (2021-2026) & (US$/Unit) Table 128. North America Buspirone Sales Price by Type (2027-2032) & (US$/Unit) Table 129. North America Buspirone Revenue by Application (2021-2026) & (US$ Million) Table 130. North America Buspirone Revenue by Application (2027-2032) & (US$ Million) Table 131. North America Buspirone Sales by Application (2021-2026) & (K Units) Table 132. North America Buspirone Sales by Application (2027-2032) & (K Units) Table 133. North America Buspirone Sales Price by Application (2021-2026) & (US$/Unit) Table 134. North America Buspirone Sales Price by Application (2027-2032) & (US$/Unit) Table 135. North America Buspirone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. North America Buspirone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 137. North America Buspirone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 138. North America Buspirone Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 139. North America Buspirone Sales by Country (2021-2026) & (K Units) Table 140. North America Buspirone Sales by Country (2027-2032) & (K Units) Table 141. North America Buspirone Sales Price by Country (2021-2026) & (US$/Unit) Table 142. North America Buspirone Sales Price by Country (2027-2032) & (US$/Unit) Table 143. United States Buspirone Revenue (2021-2032) & (US$ Million) Table 144. Canada Buspirone Revenue (2021-2032) & (US$ Million) Table 145. Europe Buspirone Revenue by Type (2021-2026) & (US$ Million) Table 146. Europe Buspirone Revenue by Type (2027-2032) & (US$ Million) Table 147. Europe Buspirone Sales by Type (2021-2026) & (K Units) Table 148. Europe Buspirone Sales by Type (2027-2032) & (K Units) Table 149. Europe Buspirone Sales Price by Type (2021-2026) & (US$/Unit) Table 150. Europe Buspirone Sales Price by Type (2027-2032) & (US$/Unit) Table 151. Europe Buspirone Revenue by Application (2021-2026) & (US$ Million) Table 152. Europe Buspirone Revenue by Application (2027-2032) & (US$ Million) Table 153. Europe Buspirone Sales by Application (2021-2026) & (K Units) Table 154. Europe Buspirone Sales by Application (2027-2032) & (K Units) Table 155. Europe Buspirone Sales Price by Application (2021-2026) & (US$/Unit) Table 156. Europe Buspirone Sales Price by Application (2027-2032) & (US$/Unit) Table 157. Europe Buspirone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Europe Buspirone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 159. Europe Buspirone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 160. Europe Buspirone Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 161. Europe Buspirone Sales by Country (2021-2026) & (K Units) Table 162. Europe Buspirone Sales by Country (2027-2032) & (K Units) Table 163. Europe Buspirone Sales Price by Country (2021-2026) & (US$/Unit) Table 164. Europe Buspirone Sales Price by Country (2027-2032) & (US$/Unit) Table 165. Germany Buspirone Revenue (2021-2032) & (US$ Million) Table 166. France Buspirone Revenue (2021-2032) & (US$ Million) Table 167. U.K. Buspirone Revenue (2021-2032) & (US$ Million) Table 168. Italy Buspirone Revenue (2021-2032) & (US$ Million) Table 169. Netherlands Buspirone Revenue (2021-2032) & (US$ Million) Table 170. China Buspirone Revenue by Type (2021-2026) & (US$ Million) Table 171. China Buspirone Revenue by Type (2027-2032) & (US$ Million) Table 172. China Buspirone Sales by Type (2021-2026) & (K Units) Table 173. China Buspirone Sales by Type (2027-2032) & (K Units) Table 174. China Buspirone Sales Price by Type (2021-2026) & (US$/Unit) Table 175. China Buspirone Sales Price by Type (2027-2032) & (US$/Unit) Table 176. China Buspirone Revenue by Application (2021-2026) & (US$ Million) Table 177. China Buspirone Revenue by Application (2027-2032) & (US$ Million) Table 178. China Buspirone Sales by Application (2021-2026) & (K Units) Table 179. China Buspirone Sales by Application (2027-2032) & (K Units) Table 180. China Buspirone Sales Price by Application (2021-2026) & (US$/Unit) Table 181. China Buspirone Sales Price by Application (2027-2032) & (US$/Unit) Table 182. Asia Buspirone Revenue by Type (2021-2026) & (US$ Million) Table 183. Asia Buspirone Revenue by Type (2027-2032) & (US$ Million) Table 184. Asia Buspirone Sales by Type (2021-2026) & (K Units) Table 185. Asia Buspirone Sales by Type (2027-2032) & (K Units) Table 186. Asia Buspirone Sales Price by Type (2021-2026) & (US$/Unit) Table 187. Asia Buspirone Sales Price by Type (2027-2032) & (US$/Unit) Table 188. Asia Buspirone Revenue by Application (2021-2026) & (US$ Million) Table 189. Asia Buspirone Revenue by Application (2027-2032) & (US$ Million) Table 190. Asia Buspirone Sales by Application (2021-2026) & (K Units) Table 191. Asia Buspirone Sales by Application (2027-2032) & (K Units) Table 192. Asia Buspirone Sales Price by Application (2021-2026) & (US$/Unit) Table 193. Asia Buspirone Sales Price by Application (2027-2032) & (US$/Unit) Table 194. Asia Buspirone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. Asia Buspirone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. Asia Buspirone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. Asia Buspirone Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 198. Asia Buspirone Sales by Country (2021-2026) & (K Units) Table 199. Asia Buspirone Sales by Country (2027-2032) & (K Units) Table 200. Asia Buspirone Sales Price by Country (2021-2026) & (US$/Unit) Table 201. Asia Buspirone Sales Price by Country (2027-2032) & (US$/Unit) Table 202. Japan Buspirone Revenue (2021-2032) & (US$ Million) Table 203. South Korea Buspirone Revenue (2021-2032) & (US$ Million) Table 204. India Buspirone Revenue (2021-2032) & (US$ Million) Table 205. Australia Buspirone Revenue (2021-2032) & (US$ Million) Table 206. China Taiwan Buspirone Revenue (2021-2032) & (US$ Million) Table 207. Southeast Asia Buspirone Revenue (2021-2032) & (US$ Million) Table 208. SAMEA Buspirone Revenue by Type (2021-2026) & (US$ Million) Table 209. SAMEA Buspirone Revenue by Type (2027-2032) & (US$ Million) Table 210. SAMEA Buspirone Sales by Type (2021-2026) & (K Units) Table 211. SAMEA Buspirone Sales by Type (2027-2032) & (K Units) Table 212. SAMEA Buspirone Sales Price by Type (2021-2026) & (US$/Unit) Table 213. SAMEA Buspirone Sales Price by Type (2027-2032) & (US$/Unit) Table 214. SAMEA Buspirone Revenue by Application (2021-2026) & (US$ Million) Table 215. SAMEA Buspirone Revenue by Application (2027-2032) & (US$ Million) Table 216. SAMEA Buspirone Sales by Application (2021-2026) & (K Units) Table 217. SAMEA Buspirone Sales by Application (2027-2032) & (K Units) Table 218. SAMEA Buspirone Sales Price by Application (2021-2026) & (US$/Unit) Table 219. SAMEA Buspirone Sales Price by Application (2027-2032) & (US$/Unit) Table 220. SAMEA Buspirone Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 221. SAMEA Buspirone Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 222. SAMEA Buspirone Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 223. SAMEA Buspirone Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 224. SAMEA Buspirone Sales by Country (2021-2026) & (K Units) Table 225. SAMEA Buspirone Sales by Country (2027-2032) & (K Units) Table 226. SAMEA Buspirone Sales Price by Country (2021-2026) & (US$/Unit) Table 227. SAMEA Buspirone Sales Price by Country (2027-2032) & (US$/Unit) Table 228. Brazil Buspirone Revenue (2021-2032) & (US$ Million) Table 229. Argentina Buspirone Revenue (2021-2032) & (US$ Million) Table 230. Chile Buspirone Revenue (2021-2032) & (US$ Million) Table 231. Colombia Buspirone Revenue (2021-2032) & (US$ Million) Table 232. Peru Buspirone Revenue (2021-2032) & (US$ Million) Table 233. Saudi Arabia Buspirone Revenue (2021-2032) & (US$ Million) Table 234. Israel Buspirone Revenue (2021-2032) & (US$ Million) Table 235. UAE Buspirone Revenue (2021-2032) & (US$ Million) Table 236. Turkey Buspirone Revenue (2021-2032) & (US$ Million) Table 237. Iran Buspirone Revenue (2021-2032) & (US$ Million) Table 238. Egypt Buspirone Revenue (2021-2032) & (US$ Million) Table 239. Key Raw Materials Table 240. Raw Materials Key Suppliers Table 241. Buspirone Distributors List Table 242. Buspirone Customers List Table 243. Research Programs/Design for This Report Table 244. Authors List of This Report Table 245. Secondary Sources Table 246. Primary Sources List of Figures Figure 1. Buspirone Image Figure 2. Global Buspirone Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Buspirone Market Size Share 2021 VS 2025 VS 2032 Figure 4. 10mg Image Figure 5. 15mg Image Figure 6. 30mg Image Figure 7. 5mg Image Figure 8. Global Buspirone Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Buspirone Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Drug Store Image Figure 12. Global Buspirone Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Buspirone Revenue (2021-2032) & (US$ Million) Figure 14. Global Buspirone Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Buspirone Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Buspirone Revenue Market Share by Region (2021-2032) Figure 17. Global Buspirone Sales (2021-2032) & (K Units) Figure 18. Global Buspirone Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Buspirone Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Buspirone Sales YoY (2021-2032) & (K Units) Figure 21. Europe Buspirone Sales YoY (2021-2032) & (K Units) Figure 22. China Buspirone Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Buspirone Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Buspirone Sales YoY (2021-2032) & (K Units) Figure 25. Global Buspirone Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Buspirone Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Buspirone Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Buspirone Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Buspirone Revenue Market Share by Type (2021-2032) Figure 31. Global Buspirone Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Buspirone Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Buspirone Sales Market Share by Type (2021-2032) Figure 34. Global Buspirone Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Buspirone Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Buspirone Revenue Market Share by Application (2021-2032) Figure 37. Global Buspirone Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Buspirone Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Buspirone Sales Market Share by Application (2021-2032) Figure 40. North America Buspirone Revenue Share by Type (2021-2032) Figure 41. North America Buspirone Sales Share by Type (2021-2032) Figure 42. North America Buspirone Revenue Share by Application (2021-2032) Figure 43. North America Buspirone Sales Share by Application (2021-2032) Figure 44. North America Buspirone Revenue Share by Country (2021-2032) Figure 45. North America Buspirone Sales Share by Country (2021-2032) Figure 46. Europe Buspirone Revenue Share by Type (2021-2032) Figure 47. Europe Buspirone Sales Share by Type (2021-2032) Figure 48. Europe Buspirone Revenue Share by Application (2021-2032) Figure 49. Europe Buspirone Sales Share by Application (2021-2032) Figure 50. Europe Buspirone Revenue Share by Country (2021-2032) Figure 51. Europe Buspirone Sales Share by Country (2021-2032) Figure 52. China Buspirone Revenue Share by Type (2021-2032) Figure 53. China Buspirone Sales Share by Type (2021-2032) Figure 54. China Buspirone Revenue Share by Application (2021-2032) Figure 55. China Buspirone Sales Share by Application (2021-2032) Figure 56. Asia Buspirone Revenue Share by Type (2021-2032) Figure 57. Asia Buspirone Sales Share by Type (2021-2032) Figure 58. Asia Buspirone Revenue Share by Application (2021-2032) Figure 59. Asia Buspirone Sales Share by Application (2021-2032) Figure 60. Asia Buspirone Revenue Share by Country (2021-2032) Figure 61. Asia Buspirone Sales Share by Country (2021-2032) Figure 62. SAMEA Buspirone Revenue Share by Type (2021-2032) Figure 63. SAMEA Buspirone Sales Share by Type (2021-2032) Figure 64. SAMEA Buspirone Revenue Share by Application (2021-2032) Figure 65. SAMEA Buspirone Sales Share by Application (2021-2032) Figure 66. SAMEA Buspirone Revenue Share by Country (2021-2032) Figure 67. SAMEA Buspirone Sales Share by Country (2021-2032) Figure 68. Buspirone Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Buspirone Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg
  • 15mg
  • 30mg
  • 5mg
Applications
  • Hospital
  • Drug Store
Companies covered
  • Teva
  • Novartis
  • Mylan
  • Wockhardt
  • Watson Laboratories
  • Orion Corporation
  • Laboratoires Servier
  • Hikma
  • Dr. Reddy's Laboratories
  • Cadila Healthcare
  • Bristol Myers Squibb
  • Apotex
  • AMAG Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Buspirone Market by Type
  3. 1.2.1 Global Buspirone Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 10mg
  5. 1.2.3 15mg
  6. 1.2.4 30mg
  7. 1.2.5 5mg
  8. 1.3 Buspirone Market by Application
  9. 1.3.1 Global Buspirone Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Drug Store
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Buspirone Market Dynamics
  1. 2.1 Buspirone Industry Trends
  2. 2.2 Buspirone Industry Drivers
  3. 2.3 Buspirone Industry Opportunities and Challenges
  4. 2.4 Buspirone Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Buspirone Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Buspirone Revenue by Region
  3. 3.2.1 Global Buspirone Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Buspirone Revenue by Region (2021-2026)
  5. 3.2.3 Global Buspirone Revenue by Region (2027-2032)
  6. 3.2.4 Global Buspirone Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Buspirone Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Buspirone Sales by Region
  9. 3.4.1 Global Buspirone Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Buspirone Sales by Region (2021-2026)
  11. 3.4.3 Global Buspirone Sales by Region (2027-2032)
  12. 3.4.4 Global Buspirone Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Buspirone Revenue by Manufacturers
  2. 4.1.1 Global Buspirone Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Buspirone Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Buspirone Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Buspirone Sales by Manufacturers
  6. 4.2.1 Global Buspirone Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Buspirone Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Buspirone Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Buspirone Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Buspirone Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Buspirone Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Buspirone Manufacturers, Product Type & Application
  13. 4.7 Global Buspirone Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Buspirone Market CR5 and HHI
  16. 4.8.2 2025 Buspirone Tier 1, Tier 2, and Tier 3
5 Buspirone Market by Type
  1. 5.1 Global Buspirone Revenue by Type
  2. 5.1.1 Global Buspirone Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Buspirone Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Buspirone Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Buspirone Sales by Type
  6. 5.2.1 Global Buspirone Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Buspirone Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Buspirone Sales Market Share by Type (2021-2032)
  9. 5.3 Global Buspirone Price by Type
6 Buspirone Market by Application
  1. 6.1 Global Buspirone Revenue by Application
  2. 6.1.1 Global Buspirone Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Buspirone Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Buspirone Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Buspirone Sales by Application
  6. 6.2.1 Global Buspirone Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Buspirone Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Buspirone Sales Market Share by Application (2021-2032)
  9. 6.3 Global Buspirone Price by Application
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva Buspirone Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Buspirone Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 Novartis
  8. 7.2.1 Novartis Company Information
  9. 7.2.2 Novartis Business Overview
  10. 7.2.3 Novartis Buspirone Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Novartis Buspirone Product Portfolio
  12. 7.2.5 Novartis Recent Developments
  13. 7.3 Mylan
  14. 7.3.1 Mylan Company Information
  15. 7.3.2 Mylan Business Overview
  16. 7.3.3 Mylan Buspirone Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Mylan Buspirone Product Portfolio
  18. 7.3.5 Mylan Recent Developments
  19. 7.4 Wockhardt
  20. 7.4.1 Wockhardt Company Information
  21. 7.4.2 Wockhardt Business Overview
  22. 7.4.3 Wockhardt Buspirone Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Wockhardt Buspirone Product Portfolio
  24. 7.4.5 Wockhardt Recent Developments
  25. 7.5 Watson Laboratories
  26. 7.5.1 Watson Laboratories Company Information
  27. 7.5.2 Watson Laboratories Business Overview
  28. 7.5.3 Watson Laboratories Buspirone Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Watson Laboratories Buspirone Product Portfolio
  30. 7.5.5 Watson Laboratories Recent Developments
  31. 7.6 Orion Corporation
  32. 7.6.1 Orion Corporation Company Information
  33. 7.6.2 Orion Corporation Business Overview
  34. 7.6.3 Orion Corporation Buspirone Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Orion Corporation Buspirone Product Portfolio
  36. 7.6.5 Orion Corporation Recent Developments
  37. 7.7 Laboratoires Servier
  38. 7.7.1 Laboratoires Servier Company Information
  39. 7.7.2 Laboratoires Servier Business Overview
  40. 7.7.3 Laboratoires Servier Buspirone Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Laboratoires Servier Buspirone Product Portfolio
  42. 7.7.5 Laboratoires Servier Recent Developments
  43. 7.8 Hikma
  44. 7.8.1 Hikma Company Information
  45. 7.8.2 Hikma Business Overview
  46. 7.8.3 Hikma Buspirone Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Hikma Buspirone Product Portfolio
  48. 7.8.5 Hikma Recent Developments
  49. 7.9 Dr. Reddy's Laboratories
  50. 7.9.1 Dr. Reddy's Laboratories Company Information
  51. 7.9.2 Dr. Reddy's Laboratories Business Overview
  52. 7.9.3 Dr. Reddy's Laboratories Buspirone Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Dr. Reddy's Laboratories Buspirone Product Portfolio
  54. 7.9.5 Dr. Reddy's Laboratories Recent Developments
  55. 7.10 Cadila Healthcare
  56. 7.10.1 Cadila Healthcare Company Information
  57. 7.10.2 Cadila Healthcare Business Overview
  58. 7.10.3 Cadila Healthcare Buspirone Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Cadila Healthcare Buspirone Product Portfolio
  60. 7.10.5 Cadila Healthcare Recent Developments
  61. 7.11 Bristol Myers Squibb
  62. 7.11.1 Bristol Myers Squibb Company Information
  63. 7.11.2 Bristol Myers Squibb Business Overview
  64. 7.11.3 Bristol Myers Squibb Buspirone Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Bristol Myers Squibb Buspirone Product Portfolio
  66. 7.11.5 Bristol Myers Squibb Recent Developments
  67. 7.12 Apotex
  68. 7.12.1 Apotex Company Information
  69. 7.12.2 Apotex Business Overview
  70. 7.12.3 Apotex Buspirone Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Apotex Buspirone Product Portfolio
  72. 7.12.5 Apotex Recent Developments
  73. 7.13 AMAG Pharmaceuticals
  74. 7.13.1 AMAG Pharmaceuticals Company Information
  75. 7.13.2 AMAG Pharmaceuticals Business Overview
  76. 7.13.3 AMAG Pharmaceuticals Buspirone Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 AMAG Pharmaceuticals Buspirone Product Portfolio
  78. 7.13.5 AMAG Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Buspirone Market Size by Type
  2. 8.1.1 North America Buspirone Revenue by Type (2021-2032)
  3. 8.1.2 North America Buspirone Sales by Type (2021-2032)
  4. 8.1.3 North America Buspirone Price by Type (2021-2032)
  5. 8.2 North America Buspirone Market Size by Application
  6. 8.2.1 North America Buspirone Revenue by Application (2021-2032)
  7. 8.2.2 North America Buspirone Sales by Application (2021-2032)
  8. 8.2.3 North America Buspirone Price by Application (2021-2032)
  9. 8.3 North America Buspirone Market Size by Country
  10. 8.3.1 North America Buspirone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Buspirone Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Buspirone Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Buspirone Market Size by Type
  2. 9.1.1 Europe Buspirone Revenue by Type (2021-2032)
  3. 9.1.2 Europe Buspirone Sales by Type (2021-2032)
  4. 9.1.3 Europe Buspirone Price by Type (2021-2032)
  5. 9.2 Europe Buspirone Market Size by Application
  6. 9.2.1 Europe Buspirone Revenue by Application (2021-2032)
  7. 9.2.2 Europe Buspirone Sales by Application (2021-2032)
  8. 9.2.3 Europe Buspirone Price by Application (2021-2032)
  9. 9.3 Europe Buspirone Market Size by Country
  10. 9.3.1 Europe Buspirone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Buspirone Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Buspirone Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Buspirone Market Size by Type
  2. 10.1.1 China Buspirone Revenue by Type (2021-2032)
  3. 10.1.2 China Buspirone Sales by Type (2021-2032)
  4. 10.1.3 China Buspirone Price by Type (2021-2032)
  5. 10.2 China Buspirone Market Size by Application
  6. 10.2.1 China Buspirone Revenue by Application (2021-2032)
  7. 10.2.2 China Buspirone Sales by Application (2021-2032)
  8. 10.2.3 China Buspirone Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Buspirone Market Size by Type
  2. 11.1.1 Asia Buspirone Revenue by Type (2021-2032)
  3. 11.1.2 Asia Buspirone Sales by Type (2021-2032)
  4. 11.1.3 Asia Buspirone Price by Type (2021-2032)
  5. 11.2 Asia Buspirone Market Size by Application
  6. 11.2.1 Asia Buspirone Revenue by Application (2021-2032)
  7. 11.2.2 Asia Buspirone Sales by Application (2021-2032)
  8. 11.2.3 Asia Buspirone Price by Application (2021-2032)
  9. 11.3 Asia Buspirone Market Size by Country
  10. 11.3.1 Asia Buspirone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Buspirone Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Buspirone Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Buspirone Market Size by Type
  2. 12.1.1 SAMEA Buspirone Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Buspirone Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Buspirone Price by Type (2021-2032)
  5. 12.2 SAMEA Buspirone Market Size by Application
  6. 12.2.1 SAMEA Buspirone Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Buspirone Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Buspirone Price by Application (2021-2032)
  9. 12.3 SAMEA Buspirone Market Size by Country
  10. 12.3.1 SAMEA Buspirone Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Buspirone Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Buspirone Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Buspirone Value Chain Analysis
  2. 13.1.1 Buspirone Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Buspirone Production Mode & Process
  6. 13.2 Buspirone Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Buspirone Distributors
  9. 13.2.3 Buspirone Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst